Your partner in radiopharmacy
Since 2004, Trasis designs, manufactures, sells and supports high performance synthesizers, dose preparation and dispensing equipment, all related consumables and shielding solutions
Products
Helping the medical community easily access new radiolabeled therapeutic and diagnostic substances.
Our nuclear medicine equipment includes automated synthesizers, dose dispensing systems, their shielding and accessories. We also develop customized synthetic methods and instruments adapted to the evolving needs of the radiochemistry industry.
Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.
About us
In a nutshell: designer and manufacturer of radiopharma instruments, ISO 9001-certified company, medical device distributor, close to its customers and partners.
What makes us different: we consider our customers' performance as our own and we put everything in place to improve it.
Our strength: every aspect of our products: design, manufacturing, commercial service, quality and support is under our full control. Our great multidisciplinary team makes this possible.
Our final goal: enable patients to have access to a wide range of radiotracers in the safest and most timely manner.
Innovating for nuclear medicine
We develop innovating equipment which enables safe manipulation and quick access to radiolabeled therapeutic and diagnostic substances.
Drug developers
Nuclear medicine departments
Drug manufacturers
- Belgium +32 4 365 86 57 EXT 2
- France +33 9 75 18 00 72
- Canada +1 780 666 41 99
- USA +1 201 588 57 52
- South America +54 11 59 84 23 04
News & Events
PRESS RELEASE: Trasis leads the way on Fibroplast Activation Protein Inhibitor [18F]ALF-FAPI-74 radiotracer production
Liège, Belgium, 18 May 2021 – Trasis, a leading manufacturer of instruments and consumables for the preparation of radiopharmaceuticals, is thrilled to announce its latest process development with the [18F]AlF-FAPI74 radiotracer, a Sofie Co. proprietary multicancer PET tracer.
Trasis Nominated for the Trends Gazelles 2021!
Trasis is nominated for the Trends Gazelles 2021, in the category of Large Companies for the Province of Liège.
For 20 years now, the editors of Trends-Tendances and Trends have been selecting between 50 and 250 Trends Gazelles in each province. These fast-growing companies are not only a source of energy for our economy but also a real inspiration for entrepreneurs.
The Trends Gazelle title is recognized in the business world because of its national reputation and regional recognition.
Our next face-to-face events
We are happy to announce that we will exhibit again during the 33rd Annual European Association of Nuclear Medicine Congress, which will take place in Vienna, from 17 to 21 October 2020. You can already contact our team to make an appointment!
We will also have the opportunity to meet you in September during the next JFMN (Journée Francophones de Médecine Nucléaire) organized in Paris, and during the CSH (Convergences Santé Hôpital) organized in Nantes in October.